Literature DB >> 8917513

The E5 gene product of rhesus papillomavirus is an activator of endogenous Ras and phosphatidylinositol-3'-kinase in NIH 3T3 cells.

J Ghai1, R S Ostrow, J Tolar, R C McGlennen, T D Lemke, D Tobolt, Z Liu, A J Faras.   

Abstract

We examined the effect of two rhesus papillomavirus 1 (RhPV) oncogenes on cytokine-induced signal transduction pathways leading to the possible activation of Ras protein (p21ras) and phosphatidylinositol kinase. p21ras in both the activated (GTP-bound) and inactivated (GDP-bound) states were quantitated. NIH 3T3 cell lines expressing the RhPV 1 E5 gene or epidermal growth factor receptor cDNA had about a sixfold higher ratio of p21ras-bound GTP to p21ras-bound GDP as compared with parental NIH 3T3 cells or a cell line expressing the RhPV 1 E7 gene under normal culture conditions, yet expressed similar levels of p21ras. Quiescent cells had dramatically reduced levels of activated p21ras, except those containing RhPV 1 E7. Levels were restored by stimulation with epidermal growth factor or platelet-derived growth factor. Both epidermal growth factor and platelet-derived growth factor receptor of RhPV 1 E5- and E7-containing cells responded to cytokine stimulation. Endogenous phosphatidylinositol-3'-kinase was up-regulated in NIH 3T3 cells transformed with the E5 genes of RhPV 1 and bovine papillomavirus 1. These results suggest that E5 genes of papillomaviruses play a major role in the regulation of transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917513      PMCID: PMC24014          DOI: 10.1073/pnas.93.23.12879

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  70 in total

1.  PDGF beta-receptor stimulates tyrosine phosphorylation of GAP and association of GAP with a signaling complex.

Authors:  D R Kaplan; D K Morrison; G Wong; F McCormick; L T Williams
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

2.  Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling.

Authors:  N Li; A Batzer; R Daly; V Yajnik; E Skolnik; P Chardin; D Bar-Sagi; B Margolis; J Schlessinger
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

3.  Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras.

Authors:  N W Gale; S Kaplan; E J Lowenstein; J Schlessinger; D Bar-Sagi
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

Review 4.  The many roads that lead to Ras.

Authors:  L A Feig
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

5.  Serological and molecular evidence of rhesus papillomavirus type 1 infections in tissues from geographically distinct institutions.

Authors:  R S Ostrow; S M Coughlin; R C McGlennen; A N Johnson; M S Ratterree; J Scheffler; N Yaegashi; D A Galloway; A J Faras
Journal:  J Gen Virol       Date:  1995-02       Impact factor: 3.891

6.  Tyrosine kinase-stimulated guanine nucleotide exchange activity of Vav in T cell activation.

Authors:  E Gulbins; K M Coggeshall; G Baier; S Katzav; P Burn; A Altman
Journal:  Science       Date:  1993-05-07       Impact factor: 47.728

7.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes.

Authors:  S W Straight; P M Hinkle; R J Jewers; D J McCance
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

8.  The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.

Authors:  M Rozakis-Adcock; R Fernley; J Wade; T Pawson; D Bowtell
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

9.  The activation of phosphatidylinositol 3-kinase by Ras.

Authors:  T Kodaki; R Woscholski; B Hallberg; P Rodriguez-Viciana; J Downward; P J Parker
Journal:  Curr Biol       Date:  1994-09-01       Impact factor: 10.834

10.  Protein kinase C-and ras-dependent activation of c-jun gene by human papillomavirus type 11 E5a oncoprotein.

Authors:  Y P Tsao; C H Huang; Y K Lin; S L Chen
Journal:  Cancer Lett       Date:  1995-08-16       Impact factor: 8.679

View more
  6 in total

1.  Differential effects of the splice acceptor at nucleotide 3295 of human papillomavirus type 31 on stable and transient viral replication.

Authors:  D J Klumpp; F Stubenrauch; L A Laimins
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide.

Authors:  W Zundel; L M Swiersz; A Giaccia
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Herpesvirus ateles gene product Tio interacts with nonreceptor protein tyrosine kinases.

Authors:  J C Albrecht; U Friedrich; C Kardinal; J Koehn; B Fleckenstein; S M Feller; B Biesinger
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

Review 4.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

5.  HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.

Authors:  Oscar Peralta-Zaragoza; Jessica Deas; Claudia Gómez-Cerón; Wendy Argelia García-Suastegui; Geny Del Socorro Fierros-Zárate; Nadia Judith Jacobo-Herrera
Journal:  Obstet Gynecol Int       Date:  2013-04-14

6.  Analysis of activated platelet-derived growth factor β receptor and Ras-MAP kinase pathway in equine sarcoid fibroblasts.

Authors:  Gennaro Altamura; Annunziata Corteggio; Lubna Nasir; Zheng Qiang Yuan; Franco Roperto; Giuseppe Borzacchiello
Journal:  Biomed Res Int       Date:  2013-07-11       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.